CROI 2024 Program Guide

Poster Sessions

384 NIS

Naive B-Cells From Unvaccinated Rhesus Macaques Cross-React With HIV gp140 Protein Michelle Premazzi Papa , Andrew Wilson, Rosemarie Mason, Jennifer A Manuzak, Nichole R Klatt, Rebecca M Lynch

Poster Session-C3 | COVID-19 Vaccines 2:30 PM - 4:00 PM • Poster Hall C-D

Poster Sessions • Monday

Complement Activation as a Mechanism of Protection by SARS CoV-2 mRNA Vaccines in Men With HIV-1 Dylan J. Tuttle , Nicolas Sluis-Cremer, Robbie B Mailliard, Charles R Rinaldo, Ernesto T Marques

385

WITHDRAWN

386

Sarbecovirus Ferritin Nanoparticle Vaccines as Protein or mRNA-LNP Elicit Broad Immunogenicity M. Gordon Joyce , Sandra V Mayer, Philip Davidson, Paul Thomas, Daniel C Douek, Monica Wu, Nicholas Clark, Amita Vaidya, William Warren, Natalie Anosova, Valerie Lecouturier, Sandhya Vasan, Nelson L Michael, Natalie Collins, for Sarbecovirus Ferritin Nanoparticle Study Group Immune Responses to an Original/BA.4-5 Bivalent Booster of SARS-CoV-2 mRNA Vaccine in PWH on ART Matteo Augello , Valeria Bono, Roberta Rovito, Alessandro Tavelli, Camilla Tincati, Alessandra Vergori, Anna Maria Azzini, Elda Righi, Andrea Antinori, Evelina Tacconelli, Antonella d’Arminio Monforte, Giulia Marchetti, for the VaxICONA-ORCHESTRA Study Group Immune Response to SARS-CoV-2 Omicron Breakthrough is a Recall of Vaccine-Induced Memory Jernej Pusnik , Jasmin Zorn, Werner O Monzon Posadas, Kathrin Peters, Emmanuil Osypchuk, Sabine Blaschke, Hendrik Streeck Long-Term Immunodominant Profile of SARS-CoV-2 T-Cell Responses in Hybrid Immunity Raúl Pérez-Caballero , Laia Bernad, Athina Kilpeläinen, Oscar Blanch Lombarte, Luis Romero, Ruth Peña, Gabriel F Rodríguez-Lozano, Josep Maria Manresa-Dominguez, Bonaventura Clotet, Alex Olvera, Christian Brander, Eva María Martínez Cáceres, Concepción Violán, Pere Torán‑Monserrat, Julia G Prado Bivalent mRNA COVID Vaccines Elicit Predominantly Cross Reactive CD4+ T-Cell Clonotypes Joel Sop , Arbor G Dykema, Caroline C Traut, Christie R Basseth, Annukka A Antar, Kellie N Smith, Joel N Blankson

387

388 NIS

389 NIS

390 NIS

391 NIS

CROI 2024 70

New Investigator Scholarship

LB

NIS

Late-Breaking